Cabergoline

  • TRADE NAME: Dostinex (Pfizer)
  • INDICATIONS: Hyperprolactinemia, Parkinsonism
  • CLASS: Dopamine receptor agonist
  • HALF-LIFE: 63–69 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Azithromycin, Levomepromazine, Risperidone, Zuclopenthixol

PREGNANCY CATEGORY: B

Our database has 28 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile

or Take a FREE TRIAL

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
OCULAR
OTHER
  • Saved Searches
  • Watch Drug

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life Threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric